We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NUVL market cap is 4.53B. The company's latest EPS is USD -1.9701 and P/E is -35.86.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -20.39M | -29.3M | -30.21M | -34.06M | -38.78M |
| Net Income | -19.72M | -26.12M | -25.19M | -29.09M | -33.65M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.36M | -16.91M | -45.82M | -86.11M | -149.49M |
| Net Income | -11.81M | -14.56M | -46.34M | -81.85M | -126.22M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 249.56M | 482.46M | 460.99M | 441.95M | 425.08M |
| Total Liabilities | 12.98M | 19.48M | 17.02M | 20.8M | 29.1M |
| Total Equity | 236.58M | 462.98M | 443.97M | 421.15M | 395.98M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.32M | 10.65M | 293.82M | 482.46M | 732.38M |
| Total Liabilities | 6.52M | 6.62M | 8.79M | 19.48M | 31.82M |
| Total Equity | -17.26M | -31.32M | 285.04M | 462.98M | 700.56M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -47.19M | -64.97M | -24.41M | -46.55M | -69.53M |
| Investing | 54.74M | -10.67M | -127.26M | -125.67M | -87.27M |
| Financing | 243k | 248.92M | -17k | 1.28M | 3.42M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.64M | -14.95M | -40M | -64.97M | -99.74M |
| Investing | N/A | N/A | -220.03M | -10.67M | -143.53M |
| Financing | N/A | 22.27M | 318.22M | 248.92M | 336.85M |
| Market Cap | 4.53B |
| Price to Earnings Ratio | -35.86 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 13.5 |
| Price to Book Ratio | 6.46 |
| Dividend Yield | - |
| Shares Outstanding | 64.07M |
| Average Volume (1 week) | 379.85k |
| Average Volume (1 Month) | 622.76k |
| 52 Week Change | 82.37% |
| 52 Week High | 89.39 |
| 52 Week Low | 35.71 |
| Spread (Intraday) | 8.63 (11.47%) |
| Company Name | Nuvalent Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.nuvalent.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
